TherapeuticsMD Inc. to Present at the 13th Annual Bio Investor Forum

BOCA RATON, Fla.--()--TherapeuticsMD Inc. (NYSE MKT:TXMD), an innovative women’s healthcare company, today announced CEO Robert G. Finizio will present an overview of the company at the 13th annual BIO Investor Forum, Wednesday, October 8 at 10:30 a.m. PDT at the Palace Hotel in San Francisco.

To listen to the live audio webcast of the presentation during the event, please visit the company's website, www.therapeuticsmd.com and click the “Investor” tab. A replay of this webcast will be available for 30 days after the initial presentation.

About TherapeuticsMD Inc.

TherapeuticsMD Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. TherapeuticsMD is developing advanced hormone therapy pharmaceutical products based on novel technologies that enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. Three phase 3 products are in the company’s development pipeline. The company also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD® and BocaGreenMD® brands. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com, www.vitamedmdrx.com and www.bocagreenmd.com.

Contacts

TherapeuticsMD Inc.
Dan Cartwright, 561-961-1900
Chief Financial Officer
Dan.Cartwright@TherapeuticsMD.com
or
Julia Amadio, 561-961-1900
Chief Product Officer
Julia.Amadio@TherapeuticsMD.com

Contacts

TherapeuticsMD Inc.
Dan Cartwright, 561-961-1900
Chief Financial Officer
Dan.Cartwright@TherapeuticsMD.com
or
Julia Amadio, 561-961-1900
Chief Product Officer
Julia.Amadio@TherapeuticsMD.com